Clinical Trial Update: ABA-101 in Participants With Progressive Multiple Sclerosis [Phase 1]

View source ↗

Summary

Abata Therapeutics is conducting a Phase 1 clinical trial of ABA-101 in participants with progressive multiple sclerosis. The study status is ACTIVE_NOT_RECRUIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• ABA-101

Snippet

Sponsor: Abata Therapeutics | Conditions: Progressive Multiple Sclerosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING